FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

22821011000001104: Rizatriptan 10mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Sep 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
75417201000001112 Rizatriptan 10mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
75417301000001115 Rizatriptan 10mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Is a Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has active ingredient Rizatriptan benzoate false Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rizatriptan 10mg tablets (Aspire Pharma Ltd) 3 tablet Has AMP True Rizatriptan 10mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Aspire Pharma Ltd) 6 tablet 2 x 3 tablets Has AMP True Rizatriptan 10mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start